Other requirements
Where the label states that Clindamycin Phosphate is sterile,it meets the requirements for
Sterilityand
Bacterial endotoxinsunder
Clindamycin for Injection.Where the label states that
Clindamycin Phosphatemust be subjected to further processing during the preparation of injectable dosage forms,it meets the requirements for
Bacterial endotoxinsunder
Clindamycin for Injection.
Assay
Buffer solution
Add 14mLof phosphoric acid to 4000mLof HPLCgrade water.Add 10mLof ammonium hydroxide,and adjust with ammonium hydroxide to a pHof 3.90±0.05.
Organic solution
Prepare a mixture of acetonitrile and methanol (900:100).
Diluent
Prepare a degassed mixture of Buffer solutionand Organic solution(80:20).
Solution A
Prepare a degassed mixture of Buffer solutionand Organic solution(920:80).
Solution B
Prepare a degassed mixture of Buffer solutionand Organic solution(520:480).
Mobile phase
Use variable mixtures of
Solution Aand
Solution Bas directed for
Chromatographic system.Make adjustments if necessary (see
System Suitabilityunder
Chromatography á621ñ).
Standard preparation
Accurately weigh about 22mg of
USP Clindamycin Phosphate RS.Add 10.0mLof
Diluent,shake briefly,and sonicate for about 5minutes to dissolve.Allow to cool to ambient temperature.
Assay preparation
Accurately weigh about 22mg of Clindamycin Phosphate.Add 10.0mLof Diluent,shake briefly,and sonicate for about 5minutes to dissolve.Allow to cool to ambient temperature.
Chromatographic system
The liquid chromatograph is equipped with a 214-nm detector and a 4.6-mm ×25-cm column that contains packing L7.The flow rate is about 1.2mLper minute.Maintain the column at a constant temperature of about 40

.The chromatograph is programmed as follows.
Time (minutes) |
Solution A
(%) |
Solution B
(%) |
Elution |
| 0 |
95.0 |
5.0 |
equilibrium |
| 040 |
95.0®5.0 |
5.0®95.0 |
linear gradient |
| 4041 |
5.0®95.0 |
95.0®5.0 |
linear gradient |
| 4146 |
95.0 |
5.0 |
isocratic |
Chromatograph the
Standard preparation,and record the peak areas as directed for
Procedure:the resolution between clindamycin phosphate and its nearest related compound is not less than 1.0,determined as follows.Between the peaks,draw a line perpendicular to the base line at the valley that separates the two peaks.The height of the valley from the base line is not more than 40percent of the height of the related compound peak.Calculate the resolution,
R,using peak widths at half height.The relative standard deviation determined from the clindamycin phosphate peak is not more than 2.0%.
Procedure
Separately inject equal volumes (about 25µL)of the
Standard preparationand the
Assay preparationinto the chromatograph,record the chromatograms,and measure the areas of the clindamycin phosphate peaks.Calculate the quantity,in µg,of clindamycin (C
18H
33ClN
2O
5S)in the portion of Clindamycin Phosphate taken by the formula:
(PWS/WU)(rU/rS),
in which
Pis the potency,in µg of clindamycin per mg,of
USP Clindamycin Phosphate RS;
WSis the weight,in mg,of
USP Clindamycin Phosphate RStaken to prepare the
Standard preparation;WUis the weight,in mg,of Clindamycin Phosphate taken to prepare the
Assay preparation;and
rUand
rSare the peak areas for clindamycin phosphate obtained from the
Assay preparationand the
Standard preparation,respectively.